发现含有乙烯基分子的N-Phenylphthalimides作为潜在的原氨基原体IX氧化酶抑制剂
Wang Geng1, Wei Zhang1, Qiong Lei1
1State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University, Guiyang 550025, P. R. China.
Journal of agricultural and food chemistry
|March 5, 2025
概括
新的N-phenylphthalimide衍生物被合成为原氨酸原蛋白IX氧化酶 (PPO) 抑制剂. 化合物B18表现出强大的除草剂活性和强大的PPO抑制,显示出新除草剂开发的前景.
科学领域:
- 农业化学 农业化学
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 原氨基原体IX氧化酶 (PPO) 抑制剂对于除草剂的开发至关重要.
- 目前仍有对新型PPO抑制剂的持续需求,这些抑制剂具有更高的疗效和更广泛的活性谱.
研究的目的:
- 设计,合成和评估新的N-phenylphthalimide衍生物作为潜在的PPO抑制剂.
- 识别具有强烈除草剂活性和对酶有利的抑制特征的化合物.
主要方法:
- 合成含有以太部分的N-phenylphthalimide衍生物.
- 酶抑制试验用于确定针对尼古提亚烟草PPO (NtPPO) 的抑制常数 (Ki).
- 在研究包括分子模拟和密度函数理论 (DFT) 计算.
主要成果:
- 化合物B18表现出强烈的NtPPO抑制,其Ki值为10.3nM,超过商业除草剂.
- 化合物A3,B18,B19和B20在每公75克每年一次的剂量下表现出广泛的除草剂活性.
- 分子模拟显示,B18与NtPPO的Arg98形成强键,并具有有利的物理化学特性.
结论:
- 化合物B18是一种高效的PPO抑制剂,也是开发新型高效除草剂的有希望的头.
- 带有以太部分的N-phenylphthalimide支架代表了一个可行的结构类,用于PPO抑制剂的发现.
- 对B18和相关化合物的进一步研究可能会导致先进的杂草管理解决方案.
相关概念视频
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Thomson's e/m Experiment
3.1K
In a beam of charged particles created by a heated cathode, the particles move at different speeds. However, many applications need a beam with uniform particle speeds. An arrangement known as a velocity selector uses electric and magnetic fields to pick particles with a particular speed from the beam.
A particle with charge q, speed v, and mass m enters an area from the top, where the magnetic and electric fields are perpendicular both to the particle's motion and to one another. The...
A particle with charge q, speed v, and mass m enters an area from the top, where the magnetic and electric fields are perpendicular both to the particle's motion and to one another. The...
3.1K
Introduction to Enzymes
17.0K
The use of enzymes by humans dates to 7000 BCE. Humans first used enzymes to ferment sugars and produce alcohol without knowing that this was an enzyme-catalyzed reaction. Wilhelm Kuhne coined the term 'enzyme' in 1877 from the Greek words ‘en’ meaning ‘in’ or ‘within’ and ‘zyme’ meaning ‘yeast.’
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
17.0K
MALDI-TOF Mass Spectrometry
4.7K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
4.7K
Genome Size and the Evolution of New Genes
7.8K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
7.8K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


